Priyamvada Maitre: BART Trial Shows Benefits of Adjuvant Radiotherapy in High-Risk Bladder Cancer
Priyamvada Maitre/ researchgate.net

Priyamvada Maitre: BART Trial Shows Benefits of Adjuvant Radiotherapy in High-Risk Bladder Cancer

Priyamvada Maitre, Radiation Oncologist at the Department of Radiation Oncology, Tata Memorial Centre, shared a post on X.

“Finally out in Journal of Clinical Oncology.

BART RCT from India’s largest phase 3 for adjuvant RT in high-risk MIBC post cystectomy.

A decade of persistence from Vedang Murthy.

Title: Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder Cancer

Authors: Vedang Murthy, Priyamvada Maitre, Mahendra Pal, Amandeep Arora, Reena Phurailatpam, Rakesh Sharma, Deleep Gudipudi, Senthil Rajappa, Lincoln Pujari, Bhavesh Bandekar, Deepa Joseph, Sadhana Kannan, Rahul Krishnatry, Ankit Misra, Amit Joshi, Vanita Noronha, Kumar Prabhash, Santosh Menon, Ganesh Bakshi, Gagan Prakas

Read the article.

Priyamvada Maitre